Author

Rick Mamelok

Institution: Cellerant Therapeutics (United States)

Observed institution: Cellerant Therapeutics (United States)

OpenAlex ID: A5016515302

A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.

2018 · Camille N. Abboud, Luke Paul Akard, et al. · Journal of Clinical Oncology · 3

Works count: 1

Citation count: 3

H-index: 1

I10-index: